29Oct
23Oct
ZetrOZ Receives Funding from the National Institute of Health to Find New Ways to Reduce Arthritic Pain for Over 60 Million Americans Using Non-Narcotic, Non-Surgical Technology
ZetrOZ Systems, developers of sustained acoustic medicine (SAM), an FDA-cleared home-use ultrasound device that helps reduce pain associated with tendon, ligament, and muscle injuries, has received funding from the National Institute of Health (NIH) to find a way to reduce arthritic pain utilizing non-surgical, non-narcotic technology. Read more >>
13Oct
Major League Baseball Teams Stand by ZetrOZ’s SAM 2.0 Ability to Help Athletes Recover From Muscle Injury Without Surgery
SAM 2.0, an FDA-cleared 2020 bio regenerative medical device that helps reduce pain associated with tendon, ligament, and muscle injuries has received positive feedback from athletes at nearly every skill level for its ability to penetrate deep into the tissue. Most notably, athletic staff from a number of professional major league baseball teams have shared their positive experiences with Sustained Acoustic Medicine-SAM, and its ability to accelerate the natural healing process without the need for surgery. Read more >>
06Oct
Elite Athletes Use ZetrOZ Systems’ sam® Technology to Heal Quicker and Avoid Surgery
sam® ultrasound, ZetrOZ Systems' sustained acoustic medicine device, is the preferred healing solution of countless professional and collegiate athletes. The wearable, long-duration ultrasound technology helps athletes avoid surgery while accelerating natural healing, proving to be extremely valuable in cases of acute and chronic pain, especially those that involve soft tissue damage. Read more >>
25Sep
ZetrOZ Systems’ Sam® Technology Provides Safer Alternative to Opioids for Pain Management
Instead of turning to potentially addictive and dangerous opioid medications, individuals suffering from chronic pain can now leverage the power of ZetrOZ Systems' Sustained Acoustic Medicine (sam®) technology to accelerate natural healing. sam® has been funded by the U.S. federal government to treat chronic pain and reduce the need for surgeries. Read more >>
18Sep
USA-Based ZetrOZ Systems Selected by the National Institute of Aging to Present the Sustained Acoustic Medicine (SAM) Medical Product Portfolio to Global Healthcare Community
ZetrOZ Systems, a leading USA-based medical device manufacturer, was selected by the National Institute of Aging to present its product portfolio on opioid/surgery free medical technology, also known as Sustained Acoustic Medicine, or SAM®.
19Aug
Veteran Health Administration Expanding Homecare Pain Management Program with Sustained Acoustic Medicine (SAM) Ultrasound Patch Technology During COVID-19
Military veteran Dr. Ervin Rodriguez, who served as a First Sergeant in the United States Army, experienced a life-changing improvement in the state of multiple chronic soft-tissue injury sites after treating them with the Sustained Acoustic Medicine (SAM®) wearable, multi-hour, ultrasound device manufactured by ZetrOZ Systems in Trumbull, CT, USA. Read more >>
16Jul
sam® Dramatically Improves the Treatment of Soft Tissue, Arthritis and Joint Issues Without Requiring Surgery or Pain Medication
sam® provides effective and safe treatment of soft tissue, arthritis and joint issues without the need for surgery or pain medication. The wearable device does so by stimulating blood flow for several hours per day to a localized region, delivering a powerful flow of nutrients to the site of an injury. Read more >>
25Jun
Ultrasound Device Offers an Alternative to Analgesics
The ZetrOZ Systems (Trumbull, CT, USA) sustained acoustic medicine (sam) is a drug free, wearable, non-invasive device that uses patented ultra-low impedance miniaturization technology to deliver long duration, low intensity ultrasound therapy. Read more >>
10Jun